ST南化(600301.SH)2019年淨利預降82%-85%
格隆匯1月16日丨ST南化(600301.SH)發佈2019年年度業績預告,預計公司2019年度實現歸屬於上市公司股東的淨利潤約為800萬元到1000萬元,與上年同期相比減少約82%到85%。歸屬於上市公司股東的扣除非經常性損益的淨利潤預計約為800萬元到1000萬元,與上年同期相比增加約1900萬元到2100萬元。
公司本次業績預減主要是上年控股子公司南寧綠洲化工有限責任公司因已進入破產重整,不再納入合併報表範圍,公司對前期承擔的超額虧損6321.08萬元進行轉回,導致本期與上年同期相比歸屬於上市公司股東的淨利潤減少,歸屬於上市公司股東的扣除非經常性損益的淨利潤增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.